Concepedia

Rick R. Reinhardt

RR

Statistics

Publications

4

Citations

756

H-Index

4

Active since

1983

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Rick R. Reinhardt is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, acute emesis, and delayed emesis.

Publications per year

1983–2002

4

Publications

4

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

Rudolph M. Navari, Rick R. Reinhardt, Richard J. Gralla et al. · New England Journal of Medicine · 1999 · 371 citations · Full text

, , +16

Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone

José Rodrigues Pereira, Rick R. Reinhardt, Carlos Carracedo et al. · Journal of Clinical Oncology · 2001 · 221 citations

, , +14

Prevention of cisplatin‐induced acute and delayed emesis by the selective neurokinin‐1 antagonists, L‐758,298 and MK‐869

Simon Van Belle, M. Lichinitser, Rudolph M. Navari et al. · Cancer · 2002 · 148 citations · Full text

, , +14

Evidence for Membrane‐Associated Choline Kinase Activity in Rat Striatum

Rick R. Reinhardt, Lynn Wecker · Journal of Neurochemistry · 1983 · 16 citations

, , +7

1–4 of 4